SCHEMBL3713016

SCHEMBL3713016

COc1ccc(C(C)(C[N+](=O)[O-])C(C)=O)cc1OC

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 2/20 0.46
CYP2C19 P33261 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.40
KDM4E B2RXH2 1/20 0.39
POLB P06746 1/20 0.39
CTDSP1 Q9GZU7 1/20 0.39
TDP1 Q9NUW8 1/20 0.39
VCP P55072 3/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
CYP2C9 P11712 1/20 0.38
TSHR P16473 1/20 0.38
MTNR1A P48039 1/20 0.38
MTNR1B P49286 1/20 0.38
ALOX5 P09917 1/20 0.38
KIF11 P52732 1/20 0.38
CA12 O43570 1/20 0.37
CA1 P00915 1/20 0.37
CA2 P00918 1/20 0.37
CA4 P22748 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1978722 0.88 ALDH1A1 (0.38) ALDH1A1CYP2C19L3MBTL1CYP1A2CYP3A4
SCHEMBL14862611 0.80 L3MBTL1 (0.43) ALDH1A1CYP2C19L3MBTL1POLBTDP1
Hydrochloric Acid SCHEMBL3714238 0.78 KIF11 (0.42) ALDH1A1CYP2C19L3MBTL1KDM4ETDP1
SCHEMBL3717026 0.77 ALDH1A1 (0.42) ALDH1A1CYP2C19L3MBTL1KDM4EPOLB
SCHEMBL602550 0.76 ALDH1A1 (0.47) ALDH1A1CYP2C19L3MBTL1KDM4EPOLB
SCHEMBL9577266 0.74 CYP3A4 (0.48) ALDH1A1CYP2C19L3MBTL1POLBTDP1
SCHEMBL31649209 0.73 ALDH1A1 (0.52) ALDH1A1CYP2C19L3MBTL1KDM4EPOLB
SCHEMBL7266587 0.73 ALDH1A1 (0.52) ALDH1A1CYP2C19L3MBTL1KDM4EPOLB
SCHEMBL604009 0.72 ALDH1A1 (0.48) ALDH1A1CYP2C19L3MBTL1KDM4EPOLB
SCHEMBL7268769 0.71 ALDH1A1 (0.47) ALDH1A1CYP2C19L3MBTL1KDM4EPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2396304-A1 TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY Exelixis, Inc. (US) 2011-12-21 EP disclosed
WO-2010093845-A1 TRIAZOLE AND IMIDAZOLE DERIVATIVES FOR USE AS TGR5 AGONISTS IN THE TREATMENT OF DIABETES AND OBESITY EXELIXIS, INC. (US) 2010-08-19 WO disclosed